Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and betadex

voriconazole has been researched along with betadex in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (12.50)29.6817
2010's17 (70.83)24.3611
2020's4 (16.67)2.80

Authors

AuthorsStudies
Burhenne, J; von Mach, MA; Weilemann, LS1
Abel, S; Allan, R; Gandelman, K; Tomaszewski, K; Webb, DJ; Wood, ND1
Bosselmann, S; McConville, JT; Nelson, NA; Peters, JI; Son, YJ; Tolman, JA; Wiederhold, NP; Williams, RO1
Damle, B; Luke, DR; Schlamm, HT; Tomaszewski, K1
Bommer, J; Burhenne, J; Czock, D; Haefeli, WE; Hafner, V; Machleidt, C; Mikus, G; Riedel, KD; Weinreich, T1
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T1
Damle, B; Luke, DR; Tomaszewski, KE; Wood, ND1
Kashyap, H; Malhotra, S; Pawar, P; Sindhu, R1
Sebestyén, Z; Szabó, B; Szepesi, K1
Graovac, A; Ibric, S; Kyriakos, K; Miletic, T1
Kashyap, H; Pahuja, P; Pawar, P1
Crommen, J; Farcas, E; Fillet, M; Moldovan, R; Roland, I; Servais, AC1
Aquilante, CL; Fish, DN; Kiser, TH; MacLaren, R; Rower, JE; Teitelbaum, I; Wempe, MF1
De Waele, E; Hendrickx, I; Honore, PM; Jacobs, R; Spapen, HD; Van Gorp, V1
Bikiaris, DN; Er, S; Giannakopoulou, S; Karavas, E; Mone, M; Pavlidou, E; Siafaka, PI; Üstündağ Okur, N1
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Han, S; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Park, C; Park, SH; Yim, DS; Yoo, JH1
Cai, Z; Lv, Y; Sun, X; Yu, L; Yu, Z1
Konuma, T; Kuroda, S; Takahashi, S; Tojo, A; Yasu, T1
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR1
Andersen, SK; Csontos, I; Démuth, B; Farkas, A; Hirsch, E; Marosi, G; Nagy, B; Nagy, ZK; Szabó, E; Vass, P; Verreck, G; Vigh, T1
Li, Y; Liu, H; Pan, H; Wu, H; Zhu, C1
Groll, A; Tragiannidis, A1
Wang, L; Zhang, Z1
Aykaç, K; Başaran, E; Büyükköroğlu, G; Demirel, M; Tunali, Y; Yenilmez, E1

Reviews

2 review(s) available for voriconazole and betadex

ArticleYear
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:8

    Topics: Animals; Antifungal Agents; beta-Cyclodextrins; Dogs; Excipients; Humans; Pyrimidines; Rats; Triazoles; Voriconazole

2010
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
    Acta pharmaceutica Hungarica, 2013, Volume: 83, Issue:2

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole

2013

Trials

2 trial(s) available for voriconazole and betadex

ArticleYear
Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies.
    Clinical drug investigation, 2008, Volume: 28, Issue:7

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Creatinine; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Renal Insufficiency; Severity of Illness Index; Solubility; Triazoles; Voriconazole

2008
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Cross-Over Studies; Female; Half-Life; Hemodiafiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Renal Dialysis; Solvents; Triazoles; Voriconazole

2010

Other Studies

20 other study(ies) available for voriconazole and betadex

ArticleYear
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
    BMC clinical pharmacology, 2006, Sep-18, Volume: 6

    Topics: Aged; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Solvents; Triazoles; Voriconazole

2006
Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2009, Volume: 72, Issue:1

    Topics: Aerosols; Animals; Area Under Curve; beta-Cyclodextrins; Chemistry, Pharmaceutical; Drug Delivery Systems; Lipopeptides; Lung; Male; Mice; Particle Size; Pharmaceutical Solutions; Plasma; Pyrimidines; Solutions; Triazoles; Voriconazole

2009
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:1

    Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole

2010
Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:3

    Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Case-Control Studies; Excipients; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Prognosis; Pyrimidines; Renal Dialysis; Tissue Distribution; Triazoles; Voriconazole

2012
Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
    BioMed research international, 2013, Volume: 2013

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adhesiveness; Animals; Antifungal Agents; Aspergillus fumigatus; beta-Cyclodextrins; Candida albicans; Cornea; Drug Delivery Systems; Drug Stability; Eye; Gels; Goats; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Microbial Sensitivity Tests; Permeability; Pyrimidines; Rheology; Temperature; Triazoles; Viscosity; Voriconazole

2013
Spray-dried voriconazole-cyclodextrin complexes: solubility, dissolution rate and chemical stability.
    Carbohydrate polymers, 2013, Oct-15, Volume: 98, Issue:1

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbohydrate Conformation; Drug Stability; Molecular Docking Simulation; Pyrimidines; Solubility; Temperature; Triazoles; Voriconazole

2013
Design and evaluation of HP-β-CD based voriconazole formulations for ocular drug delivery.
    Current drug delivery, 2014, Volume: 11, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antifungal Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cornea; Drug Delivery Systems; Goats; Hydrogen-Ion Concentration; Solubility; Surface Tension; Viscosity; Voriconazole

2014
Development and validation of a liquid chromatographic method for the stability study of a pharmaceutical formulation containing voriconazole using cellulose tris(4-chloro-3-methylphenylcarbamate) as chiral selector and polar organic mobile phases.
    Journal of chromatography. A, 2014, Oct-10, Volume: 1363

    Topics: beta-Cyclodextrins; Cellulose; Chromatography, Liquid; Phenylcarbamates; Stereoisomerism; Voriconazole

2014
Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
    Critical care (London, England), 2015, Feb-03, Volume: 19

    Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Replacement Therapy; Therapeutics; Voriconazole

2015
Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
    Critical care (London, England), 2015, May-27, Volume: 19

    Topics: Antifungal Agents; beta-Cyclodextrins; Humans; Kidney Failure, Chronic; Male; Renal Replacement Therapy; Therapeutics; Voriconazole

2015
Two Different Approaches for Oral Administration of Voriconazole Loaded Formulations: Electrospun Fibers versus β-Cyclodextrin Complexes.
    International journal of molecular sciences, 2016, Feb-25, Volume: 17, Issue:3

    Topics: Administration, Oral; Antifungal Agents; beta-Cyclodextrins; Candida; Drug Carriers; Drug Liberation; Nanofibers; Polyesters; Voriconazole

2016
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Mycoses, 2016, Volume: 59, Issue:10

    Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Aspergillosis; beta-Cyclodextrins; Creatinine; Cytochrome P-450 CYP2C19; Drug Compounding; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Voriconazole; Young Adult

2016
Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-β-Cyclodextrin Nanofibers for Ophthalmic Delivery.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antifungal Agents; Area Under Curve; beta-Cyclodextrins; Calorimetry, Differential Scanning; Drug Carriers; Drug Design; Electrochemistry; Magnetic Resonance Spectroscopy; Male; Microscopy, Electron, Scanning; Nanofibers; Ophthalmic Solutions; Polyvinyl Alcohol; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Tears; Voriconazole; X-Ray Diffraction

2016
Effect of Cumulative Intravenous Voriconazole Dose on Renal Function in Hematological Patients.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Female; Humans; Kidney; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Voriconazole; Young Adult

2018
Treatment of Suspected Invasive Fungal Infection in War Wounds.
    Military medicine, 2018, 09-01, Volume: 183, Issue:suppl_2

    Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries

2018
Continuous alternative to freeze drying: Manufacturing of cyclodextrin-based reconstitution powder from aqueous solution using scaled-up electrospinning.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 03-28, Volume: 298

    Topics: Antifungal Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Crystallization; Excipients; Freeze Drying; Powders; Solubility; Technology, Pharmaceutical; Temperature; Voriconazole

2019
Kolliphor® HS 15-cyclodextrin Complex for the Delivery of Voriconazole: Preparation, Characterization, and Antifungal Activity.
    Current drug metabolism, 2020, Volume: 21, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillus niger; beta-Cyclodextrins; Candida albicans; Cryptococcosis; Cryptococcus neoformans; Drug Carriers; Drug Liberation; Female; Male; Mice; Microbial Sensitivity Tests; Polyethylene Glycols; Stearates; Surface-Active Agents; Voriconazole

2020
Reply to letter to the Editor to 'Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin'.
    Expert opinion on drug safety, 2022, Volume: 21, Issue:1

    Topics: beta-Cyclodextrins; Humans; Voriconazole

2022
Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin.
    Expert opinion on drug safety, 2022, Volume: 21, Issue:1

    Topics: beta-Cyclodextrins; Humans; Voriconazole

2022
Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application.
    Pharmaceutical development and technology, 2022, Volume: 27, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Mice; Mycoses; Solubility; Voriconazole

2022